These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25887455)

  • 1. Structural and Kinetic Characterization of a Novel N-acetylated Aliphatic Amine Metabolite of the PRMT Inhibitor, EPZ011652.
    Rioux N; Mitchell LH; Tiller P; Plant K; Shaw J; Frost K; Ribich S; Moyer MP; Copeland RA; Chesworth R; Waters NJ
    Drug Metab Dispos; 2015 Jul; 43(7):936-43. PubMed ID: 25887455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimethocaine, a synthetic cocaine derivative: studies on its in vitro metabolism catalyzed by P450s and NAT2.
    Meyer MR; Lindauer C; Maurer HH
    Toxicol Lett; 2014 Feb; 225(1):139-46. PubMed ID: 24309420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies to prevent N-acetyltransferase-mediated metabolism in a series of piperazine-containing pyrazalopyrimidine compounds.
    Rawal J; Jones R; Payne A; Gardner I
    Xenobiotica; 2008 Sep; 38(9):1219-39. PubMed ID: 18720282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
    Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
    Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoform-selective inactivation of human arylamine N-acetyltransferases by reactive metabolites of carcinogenic arylamines.
    Liu L; Wagner CR; Hanna PE
    Chem Res Toxicol; 2009 Dec; 22(12):1962-74. PubMed ID: 19842618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of a novel N-methyl-D-aspartate receptor antagonist (SM-18400): identification of an N-acetylated metabolite and pre-clinical assessment of N-acetylation polymorphism.
    Yabuki M; Kon-Ya Y; Kataoka M; Shimizudani T; Akao K; Ito M; Kanamaru H; Nakatsuka I
    Eur J Drug Metab Pharmacokinet; 2003; 28(1):21-9. PubMed ID: 14503661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human arylamine N-acetyltransferase 1: in vitro and intracellular inactivation by nitrosoarene metabolites of toxic and carcinogenic arylamines.
    Liu L; Wagner CR; Hanna PE
    Chem Res Toxicol; 2008 Oct; 21(10):2005-16. PubMed ID: 18759501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human N-acetylation of benzidine: role of NAT1 and NAT2.
    Zenser TV; Lakshmi VM; Rustan TD; Doll MA; Deitz AC; Davis BB; Hein DW
    Cancer Res; 1996 Sep; 56(17):3941-7. PubMed ID: 8752161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens.
    Fretland AJ; Doll MA; Gray K; Feng Y; Hein DW
    Toxicol Appl Pharmacol; 1997 Feb; 142(2):360-6. PubMed ID: 9070359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species differences in metabolism of EPZ015666, an oxetane-containing protein arginine methyltransferase-5 (PRMT5) inhibitor.
    Rioux N; Duncan KW; Lantz RJ; Miao X; Chan-Penebre E; Moyer MP; Munchhof MJ; Copeland RA; Chesworth R; Waters NJ
    Xenobiotica; 2016; 46(3):268-77. PubMed ID: 26294260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
    Grant DM; Blum M; Beer M; Meyer UA
    Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetylation of etamicastat, a reversible dopamine-β-hydroxylase inhibitor.
    Loureiro AI; Fernandes-Lopes C; Bonifácio MJ; Wright LC; Soares-da-Silva P
    Drug Metab Dispos; 2013 Dec; 41(12):2081-6. PubMed ID: 24013186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of 5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine (BMS-645737): identification of an unusual N-acetylglucosamine conjugate in the cynomolgus monkey.
    Johnson BM; Kamath AV; Leet JE; Liu X; Bhide RS; Tejwani RW; Zhang Y; Qian L; Wei DD; Lombardo LJ; Shu YZ
    Drug Metab Dispos; 2008 Dec; 36(12):2475-83. PubMed ID: 18787055
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Allen CE; Doll MA; Hein DW
    Drug Metab Dispos; 2017 Dec; 45(12):1276-1281. PubMed ID: 29018032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding.
    Laurieri N; Kawamura A; Westwood IM; Varney A; Morris E; Russell AJ; Stanley LA; Sim E
    BMC Pharmacol Toxicol; 2014 Nov; 15():68. PubMed ID: 25432241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo metabolism of a gamma-secretase inhibitor BMS-299897 and generation of active metabolites in milligram quantities with a microbial bioreactor.
    Zhang D; Hanson R; Roongta V; Dischino DD; Gao Q; Sloan CP; Polson C; Keavy D; Zheng M; Mitroka J; Yeola S
    Curr Drug Metab; 2006 Dec; 7(8):883-96. PubMed ID: 17168689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reductive isoxazole ring opening of the anticoagulant razaxaban is the major metabolic clearance pathway in rats and dogs.
    Zhang D; Raghavan N; Chen SY; Zhang H; Quan M; Lecureux L; Patrone LM; Lam PY; Bonacorsi SJ; Knabb RM; Skiles GL; He K
    Drug Metab Dispos; 2008 Feb; 36(2):303-15. PubMed ID: 17984286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interspecies differences in pharmacokinetics and metabolism of S-3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethylphenyl)-propionamide: the role of N-acetyltransferase.
    Gao W; Johnston JS; Miller DD; Dalton JT
    Drug Metab Dispos; 2006 Feb; 34(2):254-60. PubMed ID: 16272403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arylamine N-acetyltransferases: characterization of the substrate specificities and molecular interactions of environmental arylamines with human NAT1 and NAT2.
    Liu L; Von Vett A; Zhang N; Walters KJ; Wagner CR; Hanna PE
    Chem Res Toxicol; 2007 Sep; 20(9):1300-8. PubMed ID: 17672512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetyltransferase expression and metabolic activation of the food-derived heterocyclic amines in the human mammary gland.
    Sadrieh N; Davis CD; Snyderwine EG
    Cancer Res; 1996 Jun; 56(12):2683-7. PubMed ID: 8665493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.